NPI: 1679518724 · TOLEDO, OH 43608 · Clinical Medical Laboratory · NPI assigned 06/20/2006
Authorized official RALSTON, KIMBERLY controls 20+ related entities in our dataset. Read more
| Authorized Official | RALSTON, KIMBERLY (VP REIMBURSEMENT) |
| NPI Enumeration Date | 06/20/2006 |
Other providers sharing the same authorized official: RALSTON, KIMBERLY
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 103,113 | $1.57M |
| 2019 | 134,577 | $1.72M |
| 2020 | 135,392 | $1.78M |
| 2021 | 158,422 | $2.36M |
| 2022 | 163,107 | $2.34M |
| 2023 | 221,169 | $2.59M |
| 2024 | 99,503 | $1.12M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 3,543 | 3,153 | $1.01M |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 34,747 | 32,622 | $946K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 34,654 | 32,526 | $938K |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 14,422 | 10,240 | $632K |
| 87660 | 40,849 | 34,940 | $546K | |
| 87480 | 42,712 | 36,645 | $513K | |
| 87510 | 42,697 | 36,638 | $492K | |
| 84443 | Thyroid stimulating hormone (TSH) | 46,657 | 42,216 | $470K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 24,345 | 21,783 | $455K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 1,032 | 1,009 | $427K |
| 80061 | Lipid panel | 48,413 | 43,302 | $425K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 22,975 | 20,098 | $386K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 15,827 | 13,937 | $374K |
| 80053 | Comprehensive metabolic panel | 52,512 | 47,524 | $363K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 4,889 | 4,509 | $334K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 17,552 | 15,577 | $309K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 53,906 | 47,570 | $263K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 5,388 | 4,964 | $231K |
| 87902 | 1,165 | 1,060 | $204K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 3,006 | 2,007 | $175K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 6,400 | 5,851 | $150K |
| 36415 | Collection of venous blood by venipuncture | 74,035 | 61,902 | $150K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 27,081 | 24,010 | $150K |
| 83036 | Hemoglobin; glycosylated (A1C) | 24,988 | 22,239 | $149K |
| 80074 | 4,588 | 4,126 | $124K | |
| 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | 697 | 557 | $110K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 3,517 | 3,210 | $106K |
| 80050 | General health panel | 7,362 | 6,673 | $103K |
| 82607 | 10,509 | 9,316 | $102K | |
| 86780 | 10,658 | 9,196 | $101K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 4,536 | 4,217 | $101K |
| 86803 | 10,318 | 9,060 | $100K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 2,539 | 2,214 | $96K |
| 84439 | 16,363 | 14,661 | $96K | |
| 87522 | Neg quan hep c or qual rna | 3,231 | 2,826 | $91K |
| 86003 | 1,060 | 842 | $84K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 3,166 | 2,862 | $83K |
| 85027 | 17,730 | 16,029 | $78K | |
| 85055 | 3,595 | 3,113 | $78K | |
| 86480 | 1,501 | 1,323 | $70K | |
| 82728 | 7,772 | 6,810 | $70K | |
| 84702 | 6,733 | 5,167 | $69K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1,961 | 1,850 | $68K |
| 80048 | Basic metabolic panel (calcium, ionized) | 13,129 | 11,705 | $67K |
| 82746 | 6,986 | 6,186 | $63K | |
| 83970 | 2,417 | 2,152 | $61K | |
| 87186 | 8,844 | 8,026 | $55K | |
| 86762 | 5,351 | 4,547 | $53K | |
| 83655 | 5,263 | 4,801 | $51K | |
| 84153 | 4,546 | 4,108 | $51K | |
| 83550 | 8,589 | 7,525 | $48K | |
| 87340 | 6,925 | 5,947 | $48K | |
| 86403 | 5,092 | 4,562 | $43K | |
| 84403 | 2,459 | 2,161 | $42K | |
| 83540 | 9,613 | 8,429 | $40K | |
| 87081 | 7,100 | 6,444 | $35K | |
| 82570 | 9,242 | 8,351 | $31K | |
| 83516 | 2,237 | 1,706 | $30K | |
| 81001 | 13,414 | 11,900 | $30K | |
| 87077 | 4,694 | 4,278 | $29K | |
| 86850 | 4,852 | 4,103 | $28K | |
| 84481 | 2,291 | 2,056 | $28K | |
| 86696 | 2,009 | 1,776 | $28K | |
| 83735 | 6,580 | 5,692 | $27K | |
| 86038 | 3,215 | 2,897 | $27K | |
| 83001 | 2,006 | 1,779 | $27K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 816 | 768 | $26K |
| 82043 | 6,797 | 6,254 | $26K | |
| 86317 | 2,123 | 1,770 | $24K | |
| 87070 | 3,912 | 3,577 | $24K | |
| 83525 | 3,047 | 2,669 | $24K | |
| 87581 | 735 | 689 | $23K | |
| 87486 | 735 | 689 | $23K | |
| 84146 | 1,605 | 1,454 | $22K | |
| 87088 | 3,912 | 3,537 | $22K | |
| 87529 | 503 | 433 | $20K | |
| 86694 | 1,949 | 1,719 | $20K | |
| 82670 | 986 | 835 | $19K | |
| 80076 | 3,571 | 3,198 | $18K | |
| 86695 | 1,951 | 1,723 | $18K | |
| 83002 | 1,331 | 1,148 | $18K | |
| 86376 | 1,593 | 1,426 | $17K | |
| 82105 | 1,547 | 1,379 | $17K | |
| 86225 | 1,849 | 1,602 | $16K | |
| 86787 | 1,706 | 1,467 | $15K | |
| 82950 | 3,925 | 3,500 | $14K | |
| 84425 | 899 | 797 | $13K | |
| 86140 | 3,866 | 3,349 | $13K | |
| 84270 | 855 | 746 | $12K | |
| 83880 | 484 | 422 | $11K | |
| 84703 | 1,785 | 1,600 | $11K | |
| 82785 | 905 | 793 | $10K | |
| 86900 | 4,780 | 4,003 | $10K | |
| 86901 | 4,780 | 4,000 | $10K | |
| 84550 | 3,113 | 2,770 | $10K | |
| 85610 | 3,136 | 2,436 | $8K | |
| 87205 | 2,658 | 2,411 | $8K | |
| 82784 | 1,013 | 860 | $8K | |
| 86800 | 715 | 612 | $8K | |
| 86430 | 1,825 | 1,650 | $8K | |
| 81003 | 4,642 | 4,225 | $7K | |
| 83020 | 821 | 690 | $7K | |
| 83690 | 1,500 | 1,335 | $7K | |
| 82977 | 1,255 | 1,148 | $7K | |
| 85651 | 2,192 | 1,989 | $6K | |
| 85018 | 3,337 | 3,053 | $6K | |
| 87653 | 239 | 233 | $6K | |
| 84480 | 679 | 577 | $6K | |
| 86704 | 724 | 592 | $6K | |
| 84156 | 2,573 | 2,197 | $6K | |
| 86765 | 563 | 501 | $5K | |
| 84460 | 1,805 | 1,650 | $5K | |
| 82248 | 1,435 | 1,346 | $5K | |
| 86735 | 511 | 465 | $5K | |
| 85652 | 2,593 | 2,297 | $5K | |
| 88342 | 90 | 68 | $4K | |
| 84630 | 572 | 490 | $4K | |
| 83883 | 396 | 374 | $4K | |
| 85014 | 1,880 | 1,770 | $4K | |
| 86706 | 419 | 407 | $4K | |
| 84590 | 472 | 396 | $3K | |
| 86200 | 410 | 315 | $3K | |
| 82565 | 1,158 | 986 | $3K | |
| 84100 | 1,374 | 1,148 | $3K | |
| 85660 | 875 | 687 | $3K | |
| 86708 | 372 | 309 | $3K | |
| 88142 | 212 | 144 | $3K | |
| 87255 | 51 | 50 | $3K | |
| 82677 | 127 | 119 | $3K | |
| 84436 | 612 | 561 | $3K | |
| 84520 | 1,230 | 1,066 | $2K | |
| 84450 | 620 | 571 | $2K | |
| 83615 | 420 | 406 | $2K | |
| 82150 | 384 | 368 | $2K | |
| 86336 | 152 | 144 | $2K | |
| 86769 | 50 | 49 | $2K | |
| 87400 | 122 | 61 | $1K | |
| 83520 | 30 | 27 | $1K | |
| 82550 | 319 | 261 | $1K | |
| 82947 | 512 | 448 | $1K | |
| 84144 | 100 | 76 | $1K | |
| 85045 | 391 | 341 | $1K | |
| 85730 | 254 | 219 | $1K | |
| 80355 | 104 | 99 | $761.47 | |
| 81120 | 13 | 12 | $753.70 | |
| 80164 | 80 | 75 | $747.98 | |
| 82533 | 63 | 52 | $640.60 | |
| 82627 | 42 | 39 | $624.87 | |
| 83721 | 223 | 175 | $617.07 | |
| 84132 | 176 | 141 | $555.62 | |
| 83013 | 13 | 12 | $523.40 | |
| 80051 | 177 | 170 | $517.96 | |
| 87015 | 82 | 81 | $466.59 | |
| 84681 | 32 | 28 | $455.63 | |
| 80349 | 44 | 42 | $435.06 | |
| 80373 | 42 | 42 | $434.95 | |
| 87210 | 106 | 103 | $395.34 | |
| 82330 | 49 | 38 | $342.07 | |
| 82397 | 25 | 13 | $340.52 | |
| 87252 | 12 | 12 | $266.35 | |
| 86665 | 12 | 12 | $261.71 | |
| 82270 | 79 | 76 | $237.18 | |
| G0472 | Hepatitis c antibody screening, for individual at high risk and other covered indication(s) | 56 | 56 | $217.87 |
| 0100U | 1,095 | 121 | $173.60 | |
| 87075 | 28 | 27 | $171.79 | |
| 82310 | 71 | 67 | $168.45 | |
| 87109 | 23 | 12 | $144.38 | |
| 86707 | 18 | 18 | $143.03 | |
| 85379 | 15 | 15 | $115.94 | |
| 81015 | 54 | 54 | $114.06 | |
| 83026 | 41 | 37 | $113.64 | |
| 84466 | 12 | 12 | $108.73 | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | 51 | 47 | $59.62 |
| 82247 | 18 | 12 | $58.19 | |
| 80069 | 15 | 12 | $47.11 | |
| 82952 | 31 | 12 | $37.49 | |
| P9603 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled | 16 | 13 | $0.00 |